NCT00512096View on ClinicalTrials.gov

Neoadjuvant Chemotherapy for Patients With Squamous Cell Carcinoma of the Penis

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 1999

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Penile Cancer
Interventions
DRUG

Ifosfamide

1200 mg/m\^2 By Vein Over 2 Hours on Days 1-3

DRUG

Paclitaxel (Taxol)

175 mg/m\^2 By Vein Over 3 Hours on Day 1

DRUG

Cisplatin

25 mg/m\^2 By Vein Over 2 Hours on Days 1-3

Trial Locations (1)

77030

U.T.M.D. Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT00512096 - Neoadjuvant Chemotherapy for Patients With Squamous Cell Carcinoma of the Penis | Biotech Hunter | Biotech Hunter